Table 3:

Tumor perfusion parameters by LRC status, before, during, and after RTa

ParameterLocoregional StatusBaseline Prior to RT, LRF (n = 2); LRC (n = 13)During RT (SD)6 Weeks Post-RT, LRF (n = 2); LRC (n = 10)
Week 2, LRF (n = 2); LRC (n = 13)Week 4, LRF (n = 2); LRC (n = 12)Week 6, LRF (n = 1); LRC (n = 10)
BF (mL/100 g/min)LRF53.4 (1.8)43.9 (9.9)217.7 (243.8)16.2 (NA)28.4 (20.8)
LRC118.0 (66.1)135.8 (71.5)91.6 (51.9)137.8 (149.0)71.5 (56.6)
P value.004.0008.598NA.122
BV (ml/100 g)LRF4.5 (1.9)3.6 (1.1)6.7 (6.2)2.3 (NA)3.2 (3.1)
LRC5.6 (2.0)6.1 (2.5)4.6 (2.2)6.2 (4.9)4.0 (2.8)
P value.546.081.721NA.766
MTT (s)LRF6.4 (2.0)7.2 (2.8)3.5 (1.8)11.1 (NA)7.8 (2.2)
LRC4.9 (2.6)4.4 (2.2)5.1 (4.7)4.2 (1.3)5.7 (2.5)
P value.461.379.438NA.381
CP (mL/100 g/min)LRF7.7 (2.3)6.6 (5.6)29.5 (28.5)4.4 (NA)9.9 (9.2)
LRC16.6 (9.3)22.0 (7.5)19.0 (11.1)11.3 (8.1)15.6 (8.9)
P value.02.098.694NA.537
  • a Data are presented as a mean ± SD. P values are calculated from an independent samples t test comparing mean CTP parameter values in the LRC versus LRF groups. CTP parameters were not measured at week 6 in 1 of the 2 patients with LRF; these are indicated by NA.